Methods and devices for accurately classifying cardiac activity

• US 8,160,686 B2
• Filed: 03/06/2009
• Issued: 04/17/2012
• Est. Priority Date: 03/07/2008
• Status: Active Grant

• Current Assignee: Cameron Incorporated (Schlumberger NV)
• Original Assignee: Cameron Incorporated (Schlumberger NV)
• Inventors: Allavatam, Venugopal, Palreddy, Surekha, Sanghera, Rick, Warren, Jay A.
• Primary Examiner(s): Bertram, Eric D.
• Application Number:
  US12/399,914
• Publication Number:
  US 20090259271A1
• Time in Patent Office: 1,138 Days
• Field of Search: 600/508, 600/509, 600/516
• US Class Current: 600/516
• CPC Class Codes: A61B 5/024 Detecting, measuring or recording pulse rate or heart rate A61B5/0205, A61B5/021 take precedence
• CPC Class Codes: A61B 5/316 Modalities, i.e. specific diagnostic methods
• CPC Class Codes: A61B 5/349 Detecting specific parameters of the electrocardiograph cycle
• CPC Class Codes: A61B 5/6847 mounted on an invasive device
• CPC Class Codes: A61B 5/726 using Wavelet transforms
• CPC Class Codes: A61N 1/3704 Circuits specially adapted therefor, e.g. for sensitivity control
• CPC Class Codes: A61N 1/3956 Implantable devices for applying electric shocks to the heart, e.g. for cardioversion
• CPC Class Codes: A61N 1/3987 characterised by the timing or triggering of the shock

Abstract

Methods, systems, and devices for signal analysis in an implanted cardiac monitoring and treatment device such as an implantable cardioverter defibrillator. In illustrative examples, captured data including detected events is analyzed to identify likely overdetection of cardiac events. In some illustrative examples, when overdetection is identified, data may be modified to correct for overdetection, to reduce the impact of overdetection, or to ignore overdetected data. New methods for organizing the use of morphology and rate analysis in an overall architecture for rhythm classification and cardiac signal analysis are also discussed.

Claims

1. An implantable cardiac stimulus device (ICSD) comprising a canister housing operational circuitry and a lead electrode assembly including a plurality of electrodes disposed thereon, with the lead electrode assembly configured to couple to the canister to electrically couple the operational circuitry to the electrodes on the lead electrode assembly, the operational circuitry being configured to perform a method of cardiac signal analysis comprising:

the operational circuitry detecting a series of events;

the operational circuitry analyzing a detection interval between consecutive detected events and the operational circuitry comparing the detection interval to a wide-complex (WC) detection interval threshold;

if the detection interval is less than the WC detection interval threshold, the operational circuitry determines whether at least one of the following is also true;

a) the consecutive detected events differ in polarity, where polarity is determined by observing whether a maximum or a minimum amplitude occurs first in time in the shape of each of the consecutive detected events;

or

b) an interval between the latter of the minimum or maximum amplitude point for the first-in-time of the consecutive detected events and the first of the minimum or maximum amplitude point for the second-in-time of the consecutive detected events is less than an event peak threshold; and

if the operational circuitry determines that either a) or b) is true, the operational circuitry determines that one of the consecutive detected events is due to overdetection.

2. The ICSD of claim 1 wherein the operational circuitry is further configured to also determine whether a malignant cardiac rhythm is occurring and, if so, to deliver electrical therapy in response to the malignant cardiac rhythm.

3. The ICSD of claim 1 wherein the operational circuitry is further configured to perform the following in the method of cardiac signal analysis:

initially marking each detected event as it is detected as True;

whenever it is determined that one of the consecutive detected events is due to overdetection and neither event has been previously marked as False;

c) if a morphology template is available, marking as False whichever of the consecutive detected events is less correlated to the morphology template;

d) otherwise, marking as False the later-in-time of the consecutive detected events;

determining whether a pattern indicating overdetection has been identified and;

m) if a pattern has been identified, when a True-False-True sequence occurs, marking the False detected event as an overdetection and defining a single combined interval between the True events of the True-False-True sequence;

n) if no pattern, when a True-False-True sequence occurs, marking the False detected event as suspect;

certifying intervals between detected events for use in rate calculation if;

x) the interval is a combined interval;

or

y) the interval is between detected events that have not been marked as suspect or as overdetections; and

performing a rate calculation as part of determining whether the patient has a malignant cardiac rhythm.

4. The ICSD of claim 3 wherein the operational circuitry is further configured to perform waveform appraisal on each detected event prior to performing analysis of detection intervals, the waveform appraisal step including observation of data relating to noise occurring in the signal during a time period associated with each detected event, wherein, if noise exceeds threshold level, the detected event is marked as suspect.

5. A method of cardiac signal analysis in an implantable cardiac stimulus device (ICSD) comprising a canister housing operational circuitry and a lead electrode assembly including a plurality of electrodes disposed thereon, with the lead electrode assembly configured to couple to the canister to electrically couple the operational circuitry to the electrodes on the lead electrode assembly, the method of cardiac signal analysis comprising:

the operational circuitry detecting a series of events;

the operational circuitry analyzing a detection interval between a pair of consecutive detected events from the series of events and the operational circuitry comparing the detection interval to a wide-complex (WC) detection interval threshold;

the operational circuitry finding that the detection interval is less than the WC detection interval threshold and then the operational circuitry determining whether at least one of the following is also true;

a) the consecutive detected events differ in polarity, where polarity is determined by observing whether a maximum or a minimum amplitude occurs first in time in the shape of each of the consecutive detected events;

or

b) an interval between the latter of the minimum or maximum amplitude point for the first-in-time of the consecutive detected events and the first of the minimum or maximum amplitude point for the second-in-time of the consecutive detected events is less than an event peak threshold; and

the operational circuitry finding at least one of a) or b) is true and as a result of at least one of a) or b) being true, the operational circuitry determining that one of the consecutive detected events is due to overdetection.

6. The method of claim 5 further comprising using those events of the series of detected events to determine whether a malignant cardiac rhythm is occurring and, if so, delivering electrical therapy in response to the malignant cardiac rhythm.

7. The method of claim 5 further comprising:

initially marking each detected event as it is detected as True;

when it is determined that one of the consecutive detected events is due to overdetection and neither event has been previously marked as False;

c) if a morphology template is available, marking as False whichever of the consecutive detected events is less correlated to the morphology template;

d) otherwise, marking as False the later-in-time of the consecutive detected events;

determining whether a pattern indicating overdetection has been identified and;

m) if a pattern has been identified, when a True-False-True sequence occurs, marking the False detected event as an overdetection and defining a single combined interval between the True events of the True-False-True sequence;

n) if no pattern, when a True-False-True sequence occurs, marking the False detected event as suspect;

certifying intervals between detected events for use in rate calculation if;

x) the interval is a combined interval;

or)

y) the interval is between detected events that have not been marked as suspect or as overdetections; and

performing a rate calculation as part of determining whether the patient has a malignant cardiac rhythm.

8. The method of claim 7 further comprising performing waveform appraisal on each detected event prior to performing analysis of detection intervals, the waveform appraisal step including observation of data relating to noise occurring in the signal during a time period associated with each detected event, wherein, if noise exceeds threshold level, the detected event is marked as suspect.